Raymond James

Raymond James & Associates, Inc.

Raymond James is the brokerage and capital markets franchise of Raymond James Financial, a diversified financial services firm in St. Petersburg, Florida. Its equity research, published by Raymond James & Associates and Canada's Raymond James Ltd., focuses on small- and mid-cap companies.

Company history

Bob James founded Robert A. James Investments in St. Petersburg, Florida, in 1962; a 1964 deal with Edward Raymond's Raymond and Associates created Raymond James & Associates. The equity research department began operating in 1972, and Raymond James Financial went public in 1983. The 2001 purchase of Goepel McDermid created Canadian affiliate Raymond James Ltd., and the 2012 acquisition of Morgan Keegan expanded its capital markets business. Paul Shoukry became chief executive in February 2025.

  1. 1962Bob James founds Robert A. James Investments in St. Petersburg
  2. 1964Deal with Raymond and Associates forms Raymond James & Associates
  3. 1972Equity Research department begins operations
  4. 1983Raymond James Financial completes initial public offering
  5. 2001Acquires Goepel McDermid, renamed Raymond James Ltd. in Canada
  6. 2012Acquires Morgan Keegan & Company

Research

More than 60 analysts cover about 1,200 companies in ten industries—consumer, energy, financial services, healthcare, industrials, mining, real estate, sustainability, technology and communications, and transportation—as of 2025. The firm publishes an annual Analysts' Best Picks list. Ratings are Strong Buy, Outperform, Market Perform and Underperform, benchmarked to the S&P 500 (S&P/TSX in Canada) over six to 18 months depending on the rating.

Coverage12M

Stocks
752
Ratings
774
Price targets
985
Median upside
+19.3%
Upgrades
113
Downgrades
118
Initiations
71
Reiterations
472
Targets raised
501
Targets cut
215
  • Positive79%430
  • Neutral19%102
  • Negative2%13

Sectors

  • Financials22%
  • Health Care17%
  • Information Technology14%
  • Energy9%
  • Industrials8%
  • Consumer Discretionary8%
  • Real Estate7%

Ratings

  • Outperform54%
  • Strong Buy29%
  • Market Perform15%
  • Underperform2%
  • Buy1%

Listing

  • United States86%
  • Canada5%
  • United Kingdom1%
  • Israel1%

Activity24M

RatingsPrice targets330
Oct 2024 · Ratings 73 · Price targets 51Nov 2024 · Ratings 67 · Price targets 10Dec 2024 · Ratings 34 · Price targets 7Jan 2025 · Ratings 117 · Price targets 24Feb 2025 · Ratings 82 · Price targets 11Mar 2025 · Ratings 52 · Price targets 24Apr 2025 · Ratings 129 · Price targets 41May 2025 · Ratings 119 · Price targets 16Jun 2025 · Ratings 34 · Price targets 7Jul 2025 · Ratings 144 · Price targets 26Aug 2025 · Ratings 110 · Price targets 43Sep 2025 · Ratings 51 · Price targets 36Oct 2025 · Ratings 133 · Price targets 140Nov 2025 · Ratings 9 · Price targets 36Dec 2025 · Ratings 9 · Price targets 41Jan 2026 · Ratings 40 · Price targets 74Feb 2026 · Ratings 18 · Price targets 56Mar 2026 · Ratings 34 · Price targets 36Apr 2026 · Ratings 16 · Price targets 85May 2026 · Ratings 21 · Price targets 107Jun 2026 · Ratings 48 · Price targets 70Jul 2026 · Ratings 183 · Price targets 147Aug 2026 · Ratings 144 · Price targets 121Sep 2026 · Ratings 112 · Price targets 65
Oct '24Oct '25Sep '26

Most covered24M

StockRatingTargetActionsLast action
RJFRaymond James Financial, Inc.Hold$16033Sep 1
CHRWC.H. Robinson Worldwide, Inc.Outperform$19215Jul 30
APAAPA CorporationOutperform$5414Sep 2
CMGChipotle Mexican Grill, Inc.Outperform$42.5014Jul 30
JBHTJ.B. Hunt Transport Services, Inc.Outperform$30014Sep 17
MPCMarathon Petroleum CorporationOutperform$44514Sep 14
NVDANVIDIA CorporationOutperform$51514Sep 11
VLOValero Energy CorporationStrong Buy$45014Sep 14
EOGEOG Resources, Inc.Strong Buy$18613Sep 17
PARRPar Pacific Holdings, Inc.Outperform$10413Sep 14

Analysts24M

  • Strong BuyALSN · CIGI · ALGT37
  • Patrick Tyler BrownODFL · UNP · HUBG30
  • John FreemanEOG · FANG · NOG29
  • Justin JenkinsPARR · MPC · DK27
  • Simon LeopoldHPE · CIEN · AAOI23
  • Gregory PetersNP · ALL · AII20

Recent actions

StockRating actionRatingTargetDate
Rapport Therapeutics, Inc. Common StockRAPPReiterateStrong BuySep 22
MRRDFReiterateOutperformSep 22
Lexeo Therapeutics, Inc. Common StockLXEOReiterateStrong BuySep 22
Xometry, Inc.XMTRTarget$120Sep 22
RadNet, Inc.RDNTReiterateStrong BuySep 22
Western Alliance BancorporationWALInitiateOutperform$90Sep 22
Tonix Pharmaceuticals Holding Corp.TNXPReiterateStrong BuySep 22
Verizon Communications Inc.VZReiterateOutperformSep 21
CNReiterateOutperform$40Sep 21
Plains All American Pipeline, L.P.PAAReiterateStrong BuySep 21

Similar coverage12M

References

  1. Company History - Raymond Jamesraymondjames.com
  2. Equity Research - Raymond Jamesraymondjames.com
  3. Disclosures & Definitions - Raymond James Equity Researchraymondjames.com
  4. Raymond James Financial announces CEO transitionraymondjames.com
  5. Raymond James hires senior biotechnology research analyst (Mar. 5, 2025)raymondjames.com
  6. Raymond James Financial Form 10-K (fiscal 2003)sec.gov